Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Mdxhealth Sa ADR (MDXH)
Mdxhealth Sa ADR (MDXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mdxhealth Sa ADR CAP BUSINESS CENTER RUE D`ABHOOZ 31 B-4040 HERSTAL C9 4040 BEL

www.mdxhealth.com P: 324-364-2070 F: +32 42597875

Description:

MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. MDxHealth SA is based in Belgium.

Key Statistics

Overview:

Market Capitalization, $K 89,232
Enterprise Value, $K 109,262
Shares Outstanding, K 27,288
Annual Sales, $ 37,050 K
Annual Net Income, $ -44,040 K
Last Quarter Sales, $ 19,350 K
Last Quarter Net Income, $ -10,050 K
EBIT, $ -390 K
EBITDA, $ 4,520 K
60-Month Beta 0.30
% of Insider Shareholders 1.70%
% of Institutional Shareholders 20.20%
Float, K 26,824
% Float 98.30%
Short Volume Ratio 0.32

Growth:

1-Year Return -58.59%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 11/08/23
Next Earnings Date N/A
Earnings Per Share ttm -1.85
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year -700.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MDXH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -217.38%
Return-on-Assets % -36.27%
Profit Margin % -118.87%
Net Margin % N/A
Debt/Equity 1.45
Price/Sales 1.16
Price/Cash Flow N/A
Price/Book 4.99
Book Value/Share 0.65
Interest Coverage -6.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar